Arcellx, Inc.
ACLXDelisted Apr 28, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001786205
Arcellx, Inc. was delisted on Apr 28, 2026; its insiders filed their last Form 4 on Apr 28, 2026; 240 institutions reported holding it in 13F filings for Q1 2026, worth $6.52B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Arcellx, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 167
- −15 vs. Q1 2024
- Shares held
- 50.2M
- +3.25M (+6.9%) vs. Q1 2024
- Total value
- $2.77B
- −$494.3M (−15.1%) vs. Q1 2024
- New holders
- 22
- 80 more added
- Sold out
- 37
- 49 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $3.43M |
| Q1 2026 | 240 | $6.52B |
| Q4 2025 | 218 | $4.34B |
| Q3 2025 | 209 | $5.18B |
| Q2 2025 | 203 | $4.01B |
| Q1 2025 | 198 | $4.04B |
| Q4 2024 | 211 | $4.54B |
| Q3 2024 | 186 | $4.13B |
| Q2 2024 | 167 | $2.77B |
| Q1 2024 | 183 | $3.27B |
| Q4 2023 | 156 | $2.59B |
| Q3 2023 | 136 | $1.71B |
| Q2 2023 | 138 | $1.52B |
| Q1 2023 | 117 | $1.40B |
| Q4 2022 | 125 | $1.30B |
| Q3 2022 | 74 | $781.8M |
| Q2 2022 | 68 | $621.5M |
| Q1 2022 | 49 | $357.9M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Arcellx, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −142−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |